Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 02 1995, 298-303, Vol 33, No. 2
S Hashida, K Hashinaka, I Nishikata, S Oka, K Shimada, A Saitoh, A Takamizawa, H Shinagawa and E Ishikawa
Human immunodeficiency virus type 1 (HIV-1) p24 antigen was measured by an
ultrasensitive enzyme immunoassay (two-site immune complex transfer enzyme
immunoassay). The antigen was reacted simultaneously with 2,4-
dinitrophenyl-biotinyl-bovine serum albumin-anti-recombinant p24 (rp24)
Fab' conjugate and anti-rp24 Fab'-beta-D-galactosidase conjugate. The
complex that was formed, comprising the three components, was transferred
from polystyrene beads coated with affinity-purified (anti-
2,4-dinitrophenyl group) immunoglobulin G (IgG) to polystyrene beads coated
with streptavidin. The detection limit of rp24 was 2.4 fg (0.1 amol) per
assay or 0.24 pg/ml with as little as 10 microliters of serum. When sera
were treated at low pH, p24 was detected in 34 (68%) of 50 serum samples
from asymptomatic carriers, in 25 (86%) of 29 serum samples from patients
with advanced HIV-1 infection, and in none of 117 serum samples from
HIV-1-seronegative individuals. Levels of p24 in serum were inversely
correlated to those of anti-HIV-1 p24 IgG, and the recovery of rp24 added
to serum decreased to zero with increasing levels of anti-HIV-1 p24 IgG in
serum. This sensitive method may be used as a powerful tool for
investigating the disease.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Measurement of human immunodeficiency virus type 1 p24 in serum by an ultrasensitive enzyme immunoassay, the two-site immune complex transfer enzyme immunoassay
Department of Biochemistry, Medical College of Miyazaki, Japan.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|